Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is mainly about the feasibility and rationality of moderate sedation combined with acupuncture anesthesia in the application of gastroscopy and colonoscopy ,Then we evaluate the effectiveness and advantages of the combination of acupuncture anesthesia and drug anesthesia.
With the increase of the proportion of the patients who crave for performing painless gastroscopy and colonoscopy in recent years, it is crucial to seek a more secure and effective method of anesthesia or sedation. At present, the universal anesthetic method on gastroscopy and colonoscopy in China is the general anesthesia without intubation which usually uses propofol and opioid analgesics,Although the satisfaction of patients is high, the incidence of anesthesia-related complications and drug-related adverse reactions is high .The incidence of adverse events during the gastroscopy and colonoscopy is high, and the medical expense of anesthesia is high. At present, more than 2/3 of the patients undergo painless gastroscopy or colonoscopy are middle-aged and elderly patients, so the overdose which prolongs the recovery time、discharge time of patients and reduces the recovery quality of patients is common. The moderate sedation, which fundmentally does not affect hemodynamics、autonomous respiration and protective reflexes, is incomparable to general anesthesia . And acupuncture anesthesia also acts as a safe anesthetic method can provide safer analgesic effect.Theoretically,the combination of both of them is a relatively perfect and safe painless method.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| electroacupuncture(transcutaneous electrical acupuncture point stimulation )and remimazolam | Experimental | The investigator 1 combine electroacupuncture(transcutaneous acupoint electrical stimulation ) with remimazolam to sedate patients moderately to finish gastroscopy and colonoscopy. |
|
| placebo needle and remimazolam | Experimental | The investigator 1 combine placebo needle with remimazolam to sedate patients moderately to finish gastroscopy and colonoscopy. |
|
| fentanyl and remimazolam | Experimental | The investigator 1 combine fentanyl with remimazolam to sedate patients moderately to finish gastroscopy and colonoscopy. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| fentanyl | Drug | The investigator 1 use fentanyl to sedate patients coordinate with remimazolam |
|
| Measure | Description | Time Frame |
|---|---|---|
| patient satisfaction with sedation instrument,PSSI | The investigator 2 needs to use VAS scores to evaluate satisfaction about sedation feeling when they accepted gastroscopy and colonoscopy .The score ranges from 0 to10 and need patients evaluate it by themself when the gastroscopy or colonoscopy were finished.The score from 0 (extremely dissatisfied)to 10(extremely satisfied). | During gastroscopy and colonoscopy |
| clinical satisfaction with sedation instrument,CSSI | The investigator 2 needs to use VAS scores to evaluate satisfaction about doctors when they carry out the operation.The score from 0 (extremely dissatisfied)to 10(extremely satisfied). | During gastroscopy and colonoscopy |
| patient's pain score | The investigator 2 needs to use VAS scores to evaluate patients' pain score .The score from 0 (extremely dissatisfied)to 10(extremely satisfied). | During gastroscopy and colonoscopy |
| Measure | Description | Time Frame |
|---|---|---|
| the extent of cardia exposure | The investigator 2 needs to record the extent of cardia exposure to evaluate these interventions'effect on gastroscopy ,the investigator 2 use the table of the extent of preventriculus exposure(score from 1 to 4,1=the extent of exposure lower than 25%;2=the extent of exposure between 25% and 50%;3=the extent of exposure between 50%and 75%;4=the extent of exposure between 75%and 100%) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Patients with serious systemic diseases such as severe cardiopulmonary disease or hepatic diseases or renal diseases.
Patients under the age of 18.
Patients who did not sign the informed consent form.
Patients who have a history of alcohol abuse or drug abuse.
People who are allergic to anesthetic related ingredients, such as soybeans, eggs and so on.
Patients with extreme fear or anxiety about acupuncture.
Patients with relative contraindications of gastrointestinal endoscopy.
-
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Jixiangyu | Qingdao | Shandong | 266000 | China |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 31968988 | Background | Eberl S, Monteiro de Olivera N, Bourne D, Streitberger K, Fockens P, Hollmann MW, Preckel B. Effect of electroacupuncture on sedation requirements during colonoscopy: a prospective placebo-controlled randomised trial. Acupunct Med. 2020 Jun;38(3):131-139. doi: 10.1136/acupmed-2017-011459. Epub 2020 Jan 22. | |
| 35477483 | Background |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
During the examination, the acupuncture position was blocked to ensure that the acupuncture position was not visible; except for researcher 1, the only researcher who knew about the grouping of patients,All trial-related data were recorded by researcher 2 , and researcher 1 was responsible for patients'sedation.
| eletroacupuncture(transcutaneous electrical acupuncture point stimulation ) | Procedure | The investigator 1 use electroacupunture(transcutaneous electrical acupuncture point stimulation )to coordinate with remimazolam |
|
| placebo needle | Drug | The investigator 1 use placebo needle to sedate patients coordinate with remimazolam |
|
| remimazolam | Drug | The investigator 1 use remimazolam to sedate patients coordinate with eletroacupuncture(transcutaneous electrical acupuncture point stimulation )or placebo needle |
|
| During gastroscopy and colonoscopy |
| adverse reactions | The investigator 2 needs to record the adverse reactions such as nausea、emesis, salivation, restlessness, and breath holding to analyze efficacy of relate treatment. | During gastroscopy and colonoscopy |
| patient's recovery time | The investigator 2 needs to record to evaluate patient's recovery quality about patients | The end of gastroscopy and colonoscopy |
| patient's departure time | The investigator 2 needs to record patient's departure time to evaluate recovery quality about patients | The end of gastroscopy and colonoscopy |
| time to resume normal operation | The investigator 2 needs to record the time to resume normal operation about patient | The end of gastroscopy and colonoscopy |
| operation time about gastrointestinal endoscopy | The investigator 2 needs to record operation time about gastrointestinal endoscopy. | During gastroscopy and colonoscopy |
| heart rate | The investigator 2 needs to record heart rate(for example 60 times/min)before gastrointestinal endoscopy 、during gastrointestinal endoscopy and the end of gastrointestinal endoscopy respectively.(tachycardia:heart rate is more than 100 times/min;bradycardia:heart rate is less than 60 times/min) | before gastrointestinal endoscopy、during gastrointestinal endoscopy and the end of gastrointestinal endoscopy |
| pulse oximetry | The investigator 2 needs to record pulse oximetry (for example 97% )before gastrointestinal endoscopy 、during gastrointestinal endoscopy and the end of gastrointestinal endoscopy respectively.(hypoxemia:pulse oximetry is lower than 90%) | before gastrointestinal endoscopy、during gastrointestinal endoscopy and the end of gastrointestinal endoscopy |
| systolic pressure 、diastolic pressure | The investigator 2 needs to record systolic pressure 、diastolic pressure(for example 120/75mmHg ) before gastrointestinal endoscopy 、during gastrointestinal endoscopy and the end of gastrointestinal endoscopy respectively.(hypertension:systolic pressure ≥140mmHg or diastolic pressure ≥90mmHg;hypotension:systolic pressure ≤90mmHg or diastolic pressure ≤60mmHg) | before gastrointestinal endoscopy、during gastrointestinal endoscopy and the end of gastrointestinal endoscopy |
| respiratory rate | The investigator 2 needs to record respiratory rate(for example 15 times/min)before gastrointestinal endoscopy 、during gastrointestinal endoscopy and the end of gastrointestinal endoscopy respectively.(tachypnea:respiratory rate is more than 20 times/min;bradypnea:respiratory rate is less than 12 times/min) | before gastrointestinal endoscopy、during gastrointestinal endoscopy and the end of gastrointestinal endoscopy |
| Yu B, Hazlewood PJ, Yin X, Li S, Yue H, Xu K, Xu S, Mi Y. Effect of electroacupuncture on discomfort during gastroscopy: a study protocol for a randomized controlled trial. Trials. 2022 Apr 27;23(1):364. doi: 10.1186/s13063-022-06165-4. |
| 15173791 | Background | Cohen LB, Hightower CD, Wood DA, Miller KM, Aisenberg J. Moderate level sedation during endoscopy: a prospective study using low-dose propofol, meperidine/fentanyl, and midazolam. Gastrointest Endosc. 2004 Jun;59(7):795-803. doi: 10.1016/s0016-5107(04)00349-9. |
| 31525334 | Background | Qin Z, Ding Y, Xu C, Kwong JSW, Ji Y, Wu A, Wu J, Liu Z. Acupuncture vs Noninsertive Sham Acupuncture in Aging Patients with Degenerative Lumbar Spinal Stenosis: A Randomized Controlled Trial. Am J Med. 2020 Apr;133(4):500-507.e20. doi: 10.1016/j.amjmed.2019.08.038. Epub 2019 Sep 13. |
| 33691439 | Result | Chen JM, Li DD, Chen YS, Lian B, Wang XP, Guo YH, Xu XL, Huang P, Chen TF, Liu Y, Liu QQ. The effectiveness of electro-acupuncture combined with dyclonine hydrochloride in relieving the side effects of gastroscopy: a controlled trial. Ann Palliat Med. 2021 Mar;10(3):2958-2970. doi: 10.21037/apm-20-831. Epub 2021 Mar 1. |
| 38890239 | Derived | Xu JH, Tan HL, Zhang LN, Zhou ZG, Yuan L, Kong LX, Song MQ, Qi LJ, Ji XY. Transcutaneous Electrical Acupoint Stimulation Combined with Moderate Sedation of Remimazolam Tosilate in Gastrointestinal Endoscopy: A Prospective, Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Pain Ther. 2024 Aug;13(4):919-936. doi: 10.1007/s40122-024-00618-1. Epub 2024 Jun 18. |
| ID | Term |
|---|---|
| D005283 | Fentanyl |
| C522201 | remimazolam |
| ID | Term |
|---|---|
| D010880 | Piperidines |
| D006573 | Heterocyclic Compounds, 1-Ring |
| D006571 | Heterocyclic Compounds |
Not provided
Not provided